Elanco Animal Health Reports First Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Elanco Animal Health (ELAN) Tops Q1 EPS by 14c, Offers FY and Q2 Guidance
May 7, 2021 6:39 AM EDTElanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.37, $0.14 better than the analyst estimate of $0.23. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.16 billion.
GUIDANCE:
Elanco Animal Health sees FY2021 EPS of $1.00-$1.06, versus the... More
